Validation of a Prediction Model to Estimate Health Utilities Index Mark 3 Utility Scores from WOMAC Index Scores in Patients with Osteoarthritis of the Hip

Value in Health - Tập 11 - Trang 470-477 - 2008
Deborah Marshall1, Dan Pericak1, Paul Grootendorst2,3, Katherine Gooch4, Peter Faris5, Cy Frank6, Nicholas Bellamy7, George Torrance1,8,9, David Feeny9,10,11
1Global Health Economics and Outcomes, i3 Innovus, Burlington, ON, Canada
2Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada
3Department of Economics, McMaster University, Hamilton, ON, Canada
4Alberta Bone and Joint Health Institute, Calgary, AB, Canada
5Calgary Health Region, and Center for Health and Policy Studies, University of Calgary, Calgary, AB, Canada
6Department of Surgery, University of Calgary, Calgary, AB, Canada
7CONROD, University of Queensland, Brisbane, QLD, Australia
8McMaster University, Hamilton, ON, Canada
9Health Utilities Inc., Dundas, ON, Canada
10Kaiser Permanente Northwest Center for Health Research, Portland, OR, USA
11Departments of Economics and Public Health Sciences, University of Alberta and Institute of Health Economics, Edmonton, AB, Canada

Tài liệu tham khảo

Feeny, 1995, Multi-attribute health status classification systems. Health Utilities Index, Pharmacoeconomics, 7, 490, 10.2165/00019053-199507060-00004 Torrance GW, Feeny DH, Furlong W. Health Utilities Index, Technical Document.1-7-1992. McMaster University. Torrance, 1995, Multi-attribute preference functions. Health Utilities Index, Pharmacoeconomics, 7, 503, 10.2165/00019053-199507060-00005 Drummond, 1997, Cost-utility analysis Grootendorst, 2007, A model to estimate health utilities index mark 3 utility scores from WOMAC index scores in patients with osteoarthritis of the knee, J Rheumatol, 34, 534 Feeny, 1996, Health Utilities Index Furlong W, Feeny D, Torrance GW, et al. Multiplicative Multi-Attribute Utility Function for the Health Utilities Index Mark 3 (HUI3) System: A Technical Report. McMaster University Centre for Health Economics and Policy Analysis Working Paper no. 98–11. 1998. Raynauld, 2002, A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results, Osteoarthri Cartil, 10, 506, 10.1053/joca.2002.0798 Bellamy, 2004 R Development Core Team, 2005 SAS, 2005 Della Valle, 2005, High failure rate of a constrained acetabular liner in revision total hip arthroplasty, J Arthroplasty, 20, 103, 10.1016/j.arth.2005.05.005